These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 9037063)
1. CD30 induction of human immunodeficiency virus gene transcription is mediated by TRAF2. Tsitsikov EN; Wright DA; Geha RS Proc Natl Acad Sci U S A; 1997 Feb; 94(4):1390-5. PubMed ID: 9037063 [TBL] [Abstract][Full Text] [Related]
2. Induction of nuclear factor kappaB by the CD30 receptor is mediated by TRAF1 and TRAF2. Duckett CS; Gedrich RW; Gilfillan MC; Thompson CB Mol Cell Biol; 1997 Mar; 17(3):1535-42. PubMed ID: 9032281 [TBL] [Abstract][Full Text] [Related]
3. TRAF-interacting protein (TRIP): a novel component of the tumor necrosis factor receptor (TNFR)- and CD30-TRAF signaling complexes that inhibits TRAF2-mediated NF-kappaB activation. Lee SY; Lee SY; Choi Y J Exp Med; 1997 Apr; 185(7):1275-85. PubMed ID: 9104814 [TBL] [Abstract][Full Text] [Related]
4. CD30-dependent degradation of TRAF2: implications for negative regulation of TRAF signaling and the control of cell survival. Duckett CS; Thompson CB Genes Dev; 1997 Nov; 11(21):2810-21. PubMed ID: 9353251 [TBL] [Abstract][Full Text] [Related]
5. CD30/TNF receptor-associated factor interaction: NF-kappa B activation and binding specificity. Lee SY; Lee SY; Kandala G; Liou ML; Liou HC; Choi Y Proc Natl Acad Sci U S A; 1996 Sep; 93(18):9699-703. PubMed ID: 8790394 [TBL] [Abstract][Full Text] [Related]
6. Association of TRAF1, TRAF2, and TRAF3 with an Epstein-Barr virus LMP1 domain important for B-lymphocyte transformation: role in NF-kappaB activation. Devergne O; Hatzivassiliou E; Izumi KM; Kaye KM; Kleijnen MF; Kieff E; Mosialos G Mol Cell Biol; 1996 Dec; 16(12):7098-108. PubMed ID: 8943365 [TBL] [Abstract][Full Text] [Related]
7. TCR-independent CD30 signaling selectively induces IL-13 production via a TNF receptor-associated factor/p38 mitogen-activated protein kinase-dependent mechanism. Harlin H; Podack E; Boothby M; Alegre ML J Immunol; 2002 Sep; 169(5):2451-9. PubMed ID: 12193714 [TBL] [Abstract][Full Text] [Related]
8. T cell receptor-dependent cell death of T cell hybridomas mediated by the CD30 cytoplasmic domain in association with tumor necrosis factor receptor-associated factors. Lee SY; Park CG; Choi Y J Exp Med; 1996 Feb; 183(2):669-74. PubMed ID: 8627180 [TBL] [Abstract][Full Text] [Related]
9. Tumor necrosis factor receptor-associated factor (TRAF)-1, TRAF-2, and TRAF-3 interact in vivo with the CD30 cytoplasmic domain; TRAF-2 mediates CD30-induced nuclear factor kappa B activation. Ansieau S; Scheffrahn I; Mosialos G; Brand H; Duyster J; Kaye K; Harada J; Dougall B; Hübinger G; Kieff E; Herrmann F; Leutz A; Gruss HJ Proc Natl Acad Sci U S A; 1996 Nov; 93(24):14053-8. PubMed ID: 8943059 [TBL] [Abstract][Full Text] [Related]
10. CD30 contains two binding sites with different specificities for members of the tumor necrosis factor receptor-associated factor family of signal transducing proteins. Gedrich RW; Gilfillan MC; Duckett CS; Van Dongen JL; Thompson CB J Biol Chem; 1996 May; 271(22):12852-8. PubMed ID: 8662842 [TBL] [Abstract][Full Text] [Related]
11. The TRAF family of signal transducers mediates NF-kappaB activation by the TRANCE receptor. Wong BR; Josien R; Lee SY; Vologodskaia M; Steinman RM; Choi Y J Biol Chem; 1998 Oct; 273(43):28355-9. PubMed ID: 9774460 [TBL] [Abstract][Full Text] [Related]
12. Tumor necrosis factor receptor-associated factor (TRAF) 5 and TRAF2 are involved in CD30-mediated NFkappaB activation. Aizawa S; Nakano H; Ishida T; Horie R; Nagai M; Ito K; Yagita H; Okumura K; Inoue J; Watanabe T J Biol Chem; 1997 Jan; 272(4):2042-5. PubMed ID: 8999898 [TBL] [Abstract][Full Text] [Related]
13. A novel domain in the CD30 cytoplasmic tail mediates NFkappaB activation. Horie R; Aizawa S; Nagai M; Ito K; Higashihara M; Ishida T; Inoue J; Watanabe T Int Immunol; 1998 Feb; 10(2):203-10. PubMed ID: 9533448 [TBL] [Abstract][Full Text] [Related]
14. Caspase-mediated cleavage converts the tumor necrosis factor (TNF) receptor-associated factor (TRAF)-1 from a selective modulator of TNF receptor signaling to a general inhibitor of NF-kappaB activation. Henkler F; Baumann B; Fotin-Mleczek M; Weingärtner M; Schwenzer R; Peters N; Graness A; Wirth T; Scheurich P; Schmid JA; Wajant H J Biol Chem; 2003 Aug; 278(31):29216-30. PubMed ID: 12709429 [TBL] [Abstract][Full Text] [Related]
15. Human 4-1BB (CD137) signals are mediated by TRAF2 and activate nuclear factor-kappa B. Jang IK; Lee ZH; Kim YJ; Kim SH; Kwon BS Biochem Biophys Res Commun; 1998 Jan; 242(3):613-20. PubMed ID: 9464265 [TBL] [Abstract][Full Text] [Related]
16. The tumor necrosis factor-inducible zinc finger protein A20 interacts with TRAF1/TRAF2 and inhibits NF-kappaB activation. Song HY; Rothe M; Goeddel DV Proc Natl Acad Sci U S A; 1996 Jun; 93(13):6721-5. PubMed ID: 8692885 [TBL] [Abstract][Full Text] [Related]
17. TNF receptor (TNFR)-associated factor (TRAF) 3 serves as an inhibitor of TRAF2/5-mediated activation of the noncanonical NF-kappaB pathway by TRAF-binding TNFRs. Hauer J; Püschner S; Ramakrishnan P; Simon U; Bongers M; Federle C; Engelmann H Proc Natl Acad Sci U S A; 2005 Feb; 102(8):2874-9. PubMed ID: 15708970 [TBL] [Abstract][Full Text] [Related]
18. TRAF2-mediated activation of NF-kappa B by TNF receptor 2 and CD40. Rothe M; Sarma V; Dixit VM; Goeddel DV Science; 1995 Sep; 269(5229):1424-7. PubMed ID: 7544915 [TBL] [Abstract][Full Text] [Related]